TB-500 is a synthetic peptide fragment of thymosin β-4, investigated for cellular repair and angiogenesis in preclinical models.
Binds G-actin; investigated for effects on cell migration and vascular remodeling.
Extensive veterinary and preclinical literature.
- Musculoskeletal recovery research
- Tendon and ligament repair studies
- Cardiovascular tissue-remodeling investigation
PeriodDoseUnits (U-100)
Research protocol2–5 mg / week—
Adjust dose based on study design and tolerability. Consult your protocol.
For research use only. Not for human or veterinary consumption. Not FDA-approved for the treatment or prevention of any disease.